{
    "code": "02020883",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02020883",
    "time": "2020-02-25 12:34:03",
    "許可證字號": "衛署藥輸字第020883號",
    "註銷狀態": "已註銷",
    "註銷日期": "105\/05\/18",
    "註銷理由": "未展延而逾期者",
    "製造許可登錄編號": "",
    "有效日期": "99\/04\/22",
    "發證日期": "84\/04\/22",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202088302",
    "中文品名": "能滅瘤注射液２公絲\/公撮",
    "英文品名": "NOVANTRONE INJECTION 2MG\/ML",
    "適應症": "乳癌、肝癌、急性非淋巴性白血病、荷爾蒙治療無效之前列腺癌及多發性硬化症。",
    "劑型": "270注射劑",
    "包裝": "小瓶 盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "MITOXANTRONE (AS HYDROCHLORIDE)",
    "限制項目": "02輸　入",
    "申請商名稱": "1409901100  臺灣惠氏股份有限公司",
    "申請商地址": "台北市松山區健康路一五六號八樓",
    "主製造廠": [
        {
            "製造廠名稱": "FUS0356000  WYETH PARENTERALS DIVISION OF WYETH HOLDINGS CORPORATION",
            "製造廠廠址": "KM 9.7 65TH INFANTRY AVENUE CAROLINA, PUERTO RICO  00987",
            "製造廠公司地址": "",
            "製造廠國別": "PUERTO RICO",
            "製程": ""
        }
    ],
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1003091010",
            "成分名稱": "MITOXANTRONE (AS HYDROCHLORIDE)",
            "含量描述": "2",
            "含量": "2.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "020208830001.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020883&Seq=001&Type=9"
        }
    ]
}